SCHEMBL6931449

SCHEMBL6931449

CC(=O)N1CC(=S)C[C@H]1C(=O)O.CC(=O)Nc1ccccc1Oc1ccc(C[C@H](N)C(=O)O)cc1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.39
TPH1 P17752 7/20 0.38
POLB P06746 1/20 0.37
KDM4E B2RXH2 1/20 0.36
TACR2 P21452 1/20 0.36
ADRA2C P18825 1/20 0.36
BRD4 O60885 1/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
GAA P10253 2/20 0.36
PKM P14618 2/20 0.36
RECQL P46063 1/20 0.36
ALPI P09923 1/20 0.35
PTGS1 P23219 1/20 0.35
XIAP P98170 1/20 0.35
SLC7A5 Q01650 1/20 0.35
TACR1 P25103 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6934867 0.87 LTA4H (0.39) TPH1
SCHEMBL6933238 0.85 PTGS1 (0.38) TPH1GAAPKMALPIPTGS1
Phenylalanine SCHEMBL7906184 0.82 SLC7A5 (0.52) TPH1PKMALPIPTGS1XIAP
SCHEMBL7506525 0.82 ALDH1A1 (0.53) ALDH1A1TPH1POLBADRA2CBRD4
SCHEMBL7506530 0.82 ALDH1A1 (0.53) ALDH1A1TPH1POLBADRA2CBRD4
SCHEMBL7905125 0.81 ITGB1 (0.43) TPH1PKMALPIPTGS1XIAP
SCHEMBL6935180 0.81 DPP4 (0.47) PKMALPIPTGS1XIAPSLC7A5
SCHEMBL7904116 0.81 SLC7A5 (0.45) TPH1PKMALPIPTGS1XIAP
SCHEMBL6931447 0.81 CTSL (0.40) PKMALPIPTGS1XIAPSLC7A5
SCHEMBL6936891 0.80 S1PR5 (0.47) TPH1PKMALPIPTGS1XIAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0984981-B1 ANTI-INFLAMMATORY TYROSINE DERIVATIVES CELLTECH THERAPEUTICS LTD (GB) 2003-12-17 EP disclosed
US-6093696-A N-ACETYL-D-THIOPROLINE-(O-2,6-DICHLOROBENZYL)-L-TYROSINE, FOR EXAMPLE; SELECTIVELY INHIBIT THE ALPHA 4 SUBGROUP OF INTEGRINS FROM BINDING TO THEIR LIGANDS; USE IN PROPHYLAXIS OR TREATMENT OF IMMUNE OR INFLAMMATORY DISEASES CELLTECH THERAPEUTICS, LIMITED (GB) 2000-07-25 US disclosed